---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-003643"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2022-01-06T23:59:59+00:00"
generated_at: "2026-06-27T20:05:34.218106+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Agenus President and COO Jennifer Buell resigns to lead subsidiary MiNK Therapeutics

## Summary
- Dr. Jennifer Buell resigned as President and COO effective December 31, 2021.
- She becomes President and CEO of MiNK Therapeutics, a subsidiary of Agenus.
- Buell will also serve on Agenus' Executive Council to advise on pipeline synergy.
- No successor as President/COO announced.

## SEC filing metadata
- accession: 0001193125-22-003643
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2022-01-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/0001193125-22-003643-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/d646332d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-003643
- JSON: https://secwatch.observer/filing/0001193125-22-003643.json
- Plain text: https://secwatch.observer/filing/0001193125-22-003643.txt

## Key facts
- Executive change
  Jennifer Buell resigned as President and Chief Operating Officer at AGENUS INC.
  - Action: resigned
  - Role: President and Chief Operating Officer
  source text: Effective December 31, 2021, Dr. Jennifer Buell resigned as Agenus Inc.’s (the “Company”) President and Chief Operating Officer to become the President and Chief Executive Officer of MiNK Therapeutics, Inc. (“MiNK”), a subsidiary of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/0001193125-22-003643-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.